Clinical Trial: Pre-approval Single-patient Expanded Access for Talazoparib (PF-06944076)
Condition: Metastatic Castration-Resistant Prostate Cancer
Study Type: Expanded Access
Official Title: Not Provided
Brief Summary:
Provide pre-approval single-patient Expanded Access (Compassionate Use) of talazoparib for patients with metastatic castration-resistant prostate cancer.
Read more